Literature DB >> 17086103

Prognostic implications of atypical histologic features in choroid plexus papilloma.

Astrid Jeibmann1, Martin Hasselblatt, Joachim Gerss, Brigitte Wrede, Rupert Egensperger, Rudi Beschorner, Volkmar H J Hans, Christian H Rickert, Johannes E Wolff, Werner Paulus.   

Abstract

The prognostic significance of atypical histologic features in choroid plexus tumors remains uncertain. Therefore, a series of 164 choroid plexus tumors was evaluated for the presence of atypical histologic features, including mitotic activity, increased cellularity, nuclear pleomorphism, blurring of papillary growth pattern, and necrosis. The impact of histopathologic and clinical features on the probability of recurrence and survival was investigated. Twenty-four tumors displaying frank signs of malignancy were diagnosed as choroid plexus carcinoma according to World Health Organization criteria. Of 124 choroid plexus papillomas that had not received adjuvant treatment, 46 tumors (37%) displayed at least one atypical feature, including increased cellularity (n = 25 [20%]), mitotic activity (> or =2 mitoses per 10 high-power fields; n = 19 [15%]), nuclear pleomorphism (n = 16 [13%]), solid growth (n = 15 [12%]), and necrosis (n = 5 [4%]). Only one tumor-related death, but 10 recurrences, were observed on a mean observation time of 58 months. On univariate analysis, incomplete surgical resection (p = 0.03) and mitotic activity (p < 0.001) were the only clinicopathologic factors associated with recurrence. Using a multivariate model, an independent effect of mitotic activity on the probability of recurrence could be confirmed (p = 0.001). Because mitotic activity is the sole atypical histologic feature independently associated with recurrence, we propose to define atypical choroid plexus papilloma by mitotic activity (> or =2 mitoses per 10 high-power fields) corresponding to World Health Organization grade II, thus adjoining other intermediate tumor entities associated with increased mitotic activity such as atypical meningioma. Close follow up of patients harboring atypical choroid plexus papillomas may be warranted.

Entities:  

Mesh:

Year:  2006        PMID: 17086103     DOI: 10.1097/01.jnen.0000240464.26005.90

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  32 in total

Review 1.  The new World Health Organization Classification of Central Nervous System Tumors: what can the neuroradiologist really say?

Authors:  A G Osborn; K L Salzman; M M Thurnher; J H Rees; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

2.  Which therapy works better in choroid plexus carcinomas?

Authors:  Su G Berrak; Diane D Liu; Brigitte Wrede; Johannes E Wolff
Journal:  J Neurooncol       Date:  2010-10-26       Impact factor: 4.130

3.  Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors.

Authors:  Morgan L Shannon; Ryann M Fame; Kevin F Chau; Neil Dani; Monica L Calicchio; Gwenaelle S Géléoc; Hart G W Lidov; Sanda Alexandrescu; Maria K Lehtinen
Journal:  Am J Pathol       Date:  2018-03-13       Impact factor: 4.307

4.  Clinicopathologic and immunohistochemical study of choroid plexus tumors: single-institution experience in Mexican population.

Authors:  Martha Lilia Tena-Suck; Citlaltepetl Salinas-Lara; Daniel Rembao-Bojórquez; Manuel Castillejos
Journal:  J Neurooncol       Date:  2010-01-16       Impact factor: 4.130

5.  Histone acetylation resulting in resistance to methotrexate in choroid plexus cells.

Authors:  Preethi Prasad; Hernan Vasquez; Chandra M Das; Vidya Gopalakrishnan; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2008-10-14       Impact factor: 4.130

6.  Central nervous system tumors in the first year of life: a clinical and pathologic experience from a single cancer center.

Authors:  Maysa Al-Hussaini; Maisa Swaidan; Usama Al-Jumaily; Awni Musharbash
Journal:  Childs Nerv Syst       Date:  2013-03-24       Impact factor: 1.475

7.  [WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas].

Authors:  S Feiden; W Feiden
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

8.  TWIST-1 is overexpressed in neoplastic choroid plexus epithelial cells and promotes proliferation and invasion.

Authors:  Martin Hasselblatt; Sonja Mertsch; Björn Koos; Barbara Riesmeier; Heike Stegemann; Astrid Jeibmann; Manuel Tomm; Nicole Schmitz; Brigitte Wrede; Johannes E Wolff; Wei Zheng; Werner Paulus
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

9.  Platelet-derived growth factor receptor expression and activation in choroid plexus tumors.

Authors:  Björn Koos; Janna Paulsson; Malin Jarvius; Betzabe Chavez Sanchez; Brigitte Wrede; Sonja Mertsch; Astrid Jeibmann; Anne Kruse; Ove Peters; Johannes E A Wolff; Hans-Joachim Galla; Ola Söderberg; Werner Paulus; Arne Ostman; Martin Hasselblatt
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

10.  Atypical choroid plexus papilloma in an adult.

Authors:  Sung Ho Lee; Bong Jin Park; Eui Jong Kim; Young Jin Lim
Journal:  J Korean Neurosurg Soc       Date:  2009-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.